Unified Women’s Healthcare acquires Seattle menopause health startup Gennev

October 25, 2022 : Florida-based women’s health company Unified Women’s Healthcare declared Wednesday that it obtained Seattle startup Gennev for an unknown sum.

Gennev, founded as Genneve in 2016, offers telehealth services and products for women undergoing perimenopause and menopause. Gennev will persist operating as its health unit in the larger firm.

“We can take the mission that we have been doing as a singular organization and just boost it within Unified Women’s health platform,” stated Gennev founder and CEO Jill Angelo in an interview. The purchase “will enable us to scale and enhance reach much faster than persisting to raise more capital on our own,” she stated.

Gennev got $8 million funding from investors and has ten employees, plus more than a dozen agreement obstetricians and gynecologists.

By merging Unified Women’s Healthcare, “we have the largest network of menopause experts in the United States,” Angelo told.

Established in 2009, Unified Women’s Healthcare operates, affiliates, and supports in women’s healthcare companies, sustaining over 2,500 providers across 19 markets. It runs the most extensive OB-GYN physician practice management platform in the U.S. and businesses, including fertility treatment provider CCRM Fertility and Lucina, a maternity analytics platform.

Prior to creating her startup, Angelo spent more than 15 years at Microsoft in marketing and product positions. Gennev initially concentrated on sexual wellness and lubricants.

In earlier 2019, Gennev launched its telehealth services, aiming to aid the four-out-of-five women who do not receive healthcare distinct to menopause. All women will go through menopause, and the hormonal transition can possess hot flashes, disrupted sleep, stress, and other health impacts.

The enterprise sells its services and products directly to consumers and is investigating working with insurance companies to deliver care in their networks.

Angelo voiced the acquisition represents the first exit for a company managing menopause. She hopes it helps validate the idea that there is capital to be made in women’s health, and she predicts that more investments will follow. Those mergers will help women, she communicated, because they won’t need to navigate across a variety of metiers.

“We can help women better by providing them care across their continuum, no matter where they are at in their reproductive cycle in life, or their phase of life,” she stated. “I think it’s only going to be worthwhile.”